Aura Biosciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Aura Biosciences, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2021-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$112.79M	-$96.12M	-$35.25M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$106.19M	-$86.92M	-$35.25M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-1.76	$-1.75	$-8.95
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-1.76	$-1.75	–

Balance Sheet

	2025-12-31	2024-12-31	2021-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$59.52M	$31.69M	$23000
Everything the company owns that has value — cash, property, inventory, investments, and more.	$169.43M	$182.50M	$160.03M
Everything the company owes — debt, unpaid bills, and other obligations.	$32.52M	$30.53M	$7.71M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$136.91M	$151.97M	$152.31M

Cash Flow Statement

	2025-12-31	2024-12-31	2021-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$84.70M	-$79.81M	-$32.41M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$447000	$1.25M	$2.13M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$85.15M	-$81.06M	-$34.53M